Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE) - Concepedia

Concepedia

Publication | Closed Access

Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)

45

Citations

12

References

2022

Year

Takuya Higashiyama, Kiminori Sugino, Hisato Hara, Ken‐ichi Ito, Noriaki Nakashima, Naoyoshi Onoda, Masayuki Tori, Hiroshi Katoh, Naomi Kiyota, Ichiro Ota,

European Journal of Cancer

MedicineThyroid DiseasePharmacologyPhase Ii StudyAnti-cancer AgentCancer TreatmentThyroid HormoneOncologyRadiation OncologyCancer ResearchAnaplastic Thyroid Cancer

References

	Year	Citations

Page 1

Page 1